Lung Cancer Program


The Penn Difference

Innovative Research...Advanced Medicine... Service Excellence

  • Nationally recognized experts with extensive experience in diagnosing and treating lung cancer and related disorders, as well as those at risk
  • Multidisciplinary evaluation
  • Advanced testing for precise diagnosis and staging
  • Advanced treatments and technologies
  • Coordinated care throughout the experience
  • Support services and education programs
  • A reputation for sensitivity and responsiveness
  • Personalized attention
  • Innovative clinical trials
  • The backing of a major research program with immediate translation to patient care

What sets Penn's Center for Lung Cancer and Related Disorders apart?

The Abramson Cancer Center's interdisciplinary Lung Cancer Program was one of the first of its kind.

Penn created a new level of lung cancer care when it established the Center for Lung Cancer and Related Disorders in 1991. The Center has assembled a group of leading specialists in this field who have developed some of the most advanced medical treatments available today.

The program is distinguished in a number of ways including:

  • Dedicated specialists who evaluate and treat only lung disease
  • A team that includes a wide variety of experts including:
    • thoracic oncology surgeons who specialize in removing lung tumors
    • medical oncologists who treat lung diseases with chemotherapy
    • radiologists who use a variety of imaging techniques to check for the presence of tumors
    • pulmonologists with extensive experience in diagnosing lung diseases
    • pathologists who are experts in evaluating lung tissue
  • For the care of respiratory disorders, Penn is ranked among the top ten by US News and World Report.
  • A Tobacco and Environmental Carcinogenesis Program that is studying the relationships between environmental exposures and cancer with a focus on prevention of tobacco and asbestos-related cancers including lung cancer, head and neck cancer and mesothelioma.
  • A Tobacco Use Research Center (TTURC) whose mission is to translate discoveries in basic neuroscience, pharmacology, genetics, and behavioral science to improve treatment for nicotine dependence.
  • Penn interventional pulmonologists who are using a new minimally invasive technology, called endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), as a less invasive way to stage lung cancer.
  • Penn thoracic surgeons who see more thoracic patients than any other hospital in the Delaware Valley. By putting this experience to work, we offer our patients the best possible treatment outcomes.
  • Penn's thoracic surgeons who were among the first nationwide to form a separate section within a division of cardiothoracic surgery specializing in non-cardiac thoracic surgery. This means our surgeons are highly specialized, focusing their time, talents and education completely on thoracic disorders.
  • Penn thoracic oncologists who have developed new surgical procedures to treat previously inoperable lung cancer.
  • Surgeons who are expert in evaluating the risks and benefits of minimally invasive procedures versus open procedures, so that you can make the decision that's best for you.
  • Thoracic surgeons who are national leaders who have developed less invasive surgical techniques that quicken recovery and procedures that provide options for patients not available elsewhere in the country.
  • As one of the early pioneers in video assisted surgery (VATS), we have made continued advances with this and other minimally invasive techniques which enables us to perform many operations through small incisions resulting in less pain and a shorter recovery period for our patients. We have also created surgical tools now used nationally.
  • A rate for lung conserving procedures that is among the best in the country, ensuring that you will retain the highest quality of life possible.
  • Penn radiation oncologists who established current treatment standards for lung cancer.
  • Pioneers in the use of photodynamic therapy (PDT) in combination with surgery in the fight against advanced stage lung cancer.
  • The development of a treatment for mesothelioma based on work in the laboratory and continues to test its effectiveness through a National Cancer Institute grant.
  • We are a major center for lung cancer clinical trials, allowing us to provide some of the newest and best therapies to our patients.